Emmaus Life Sciences, Inc. (OTCMKTS:EMMA – Get Free Report) was the recipient of a large decrease in short interest in April. As of April 15th, there was short interest totalling 700 shares, a decrease of 12.5% from the March 31st total of 800 shares. Based on an average daily trading volume, of 800 shares, the days-to-cover ratio is presently 0.9 days.
Emmaus Life Sciences Stock Performance
EMMA stock remained flat at $0.10 during midday trading on Tuesday. The stock has a market capitalization of $6.19 million, a price-to-earnings ratio of -1.00 and a beta of 1.61. The firm’s fifty day moving average price is $0.11 and its 200 day moving average price is $0.11. Emmaus Life Sciences has a one year low of $0.05 and a one year high of $0.34.
About Emmaus Life Sciences
Further Reading
- Five stocks we like better than Emmaus Life Sciences
- The 3 Best Retail Stocks to Shop for in August
- NXP Semiconductors Will Set a New High Soon: $300 in Sight
- Best Stocks Under $5.00
- Hilton Demonstrates Asset Light is Right for Investors
- Best Aerospace Stocks Investing
- Boston Scientific Bucks the Medtech Slow Down and Raises Outlook
Receive News & Ratings for Emmaus Life Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Emmaus Life Sciences and related companies with MarketBeat.com's FREE daily email newsletter.